CHEMET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chemet, and when can generic versions of Chemet launch?
Chemet is a drug marketed by Recordati Rare and is included in one NDA.
The generic ingredient in CHEMET is succimer. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the succimer profile page.
US Patents and Regulatory Information for CHEMET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare | CHEMET | succimer | CAPSULE;ORAL | 019998-002 | Jan 30, 1991 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
